Main menu
Questions?  Contact Us

BioMed Realty Continues Recent Tear, Signs Alnylam Pharmaceuticals to 295,000-SF Lease in Cambridge

BioMed Realty Continues Recent Tear, Signs Alnylam Pharmaceuticals to 295,000-SF Lease in Cambridge
Looking to significantly expand its research & development capabilities, biopharmaceutical company Alnylam Pharmaceuticals (NYSE: ALNY) signed a lease to fully occupy BioMed Realty Trust's 675 W. Kendall St. building in Cambridge, MA. The new location affords Alnylam 295,000 square feet of Class A laboratory and office space over six stories, [read more]
Source: CoStar Group, Inc. NewsPublished on 2015-04-07
Found this useful? Sharing is caring! Share on FacebookShare on LinkedInTweet about this on TwitterShare on Google+Email this to someone

Leave a Reply

Your email address will not be published. Required fields are marked *